Cerebro Platform for cSDH
Chronic Subdural Hematoma
Pre-clinicalActive
Key Facts
About Vonova.io
Vonova is pioneering a transvascular platform to revolutionize brain access by using the venous system, thereby avoiding the risks and invasiveness of traditional craniotomy. Founded in 2020 and based in San Francisco, the company's 'Cerebro Platform' is a guided neurovascular system designed to improve recovery times and expand treatment options for millions of patients with chronic neurological disorders. Having secured seed financing and recognition as a MedTech Innovator finalist, Vonova is positioned at the intersection of neuroscience and advanced device technology to address a significant unmet clinical need.
View full company profile